Boston Scientific (BSX) Income from Continuing Operations (2016 - 2025)
Boston Scientific (BSX) has disclosed Income from Continuing Operations for 17 consecutive years, with 670000000.0 as the latest value for Q4 2025.
- Quarterly Income from Continuing Operations rose 19.22% to 670000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2893000000.0 through Dec 2025, up 56.72% year-over-year, with the annual reading at 2892000000.0 for FY2025, 56.66% up from the prior year.
- Income from Continuing Operations hit 670000000.0 in Q4 2025 for Boston Scientific, down from 756000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 795000000.0 in Q2 2025 to a low of 93000000.0 in Q4 2021.
- Historically, Income from Continuing Operations has averaged 403500000.0 across 5 years, with a median of 380000000.0 in 2021.
- Biggest five-year swings in Income from Continuing Operations: surged 3310.0% in 2021 and later crashed 67.45% in 2022.
- Year by year, Income from Continuing Operations stood at 93000000.0 in 2021, then soared by 51.61% to 141000000.0 in 2022, then surged by 257.45% to 504000000.0 in 2023, then grew by 11.51% to 562000000.0 in 2024, then rose by 19.22% to 670000000.0 in 2025.
- Business Quant data shows Income from Continuing Operations for BSX at 670000000.0 in Q4 2025, 756000000.0 in Q3 2025, and 795000000.0 in Q2 2025.